You are here

Dupixent

Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged

MSN Reuters

Thu, 04/24/25 - 11:01 am

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives

BioPharma Dive

Mon, 04/21/25 - 11:13 am

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Pharmaphorum

Tue, 04/15/25 - 09:53 am

clinical trials

Bristol Myers backs out of Dupixent fight, axing allergy asset despite phase 3 win

Fierce Biotech

Fri, 02/7/25 - 11:11 am

Bristol Myers Squibb

Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration

Fierce Pharma

Thu, 02/6/25 - 10:50 pm

Regeneron Beats Quarterly Estimates on Eczema Drug Demand; Launches Dividend Program

US News and World Report

Tue, 02/4/25 - 09:25 am

Sanofi to increase competition in atopic dermatitis market after Dupixent success

Clinical Trials Arena

Thu, 01/16/25 - 11:09 am

Kymera Therapeutics

atopic dermatitis

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

Benzinga

Fri, 11/15/24 - 11:15 am

chronic spontaneous urticaria

FDA, after delay, clears Regeneron and Sanofi drug for COPD

BioPharma Dive

Mon, 09/30/24 - 09:25 am

Sanofi's Dupixent scores double COPD win in US, China

Pharmaphorum

Mon, 09/30/24 - 09:16 am

3 FDA approval dates to watch in the year’s final push

Pharma Voice

Wed, 09/11/24 - 11:39 am

Bristol Myers Squibb

ATTR cardiomyopathy

Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound

BioPharma Dive

Wed, 09/11/24 - 11:19 am

7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run

Pharma Voice

Tue, 07/30/24 - 11:30 am

Trials to watch: Four biologics concluding pivotal COPD trials

Clinical Trials Arena

Thu, 07/25/24 - 11:36 am

clinical trials

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products

Reuters

Thu, 07/25/24 - 11:26 am

Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD

Fierce Pharma

Wed, 07/3/24 - 11:26 am

Sanofi reports positive data from Phase III EoE treatment trial

Clinical Trials Arena

Thu, 06/27/24 - 11:29 am

eosinophilic esophagitis

clinical trials

Dupixent repeats as top pharma ad brand, rankings largely unchanged in May

Medical Marketing and Media

Tue, 06/11/24 - 10:49 pm

pharma advertising

DTC advertising

Dupixent nears EU approval for COPD, as FDA delays

Pharmaphorum

Fri, 05/31/24 - 10:49 am

Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD

Fierce Pharma

Mon, 05/20/24 - 11:25 am

Pages